Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Prostate Cancer and Prostatic Diseases|September 8, 2021
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugsAnne Holck Storås, Sophie D Fosså, Giske Ursin, et al.Acta Oncologica (Stockholm, Sweden)|September 19, 2023
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort studyAnne Holck Storås, Kaitlyn Tsuruda, Sophie Dorothea Fosså, et al.European Urology Open Science|April 1, 2024
Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate CancerSophie D Fosså, Anne Holck Storås, Kirsti Aas, et al.Clinical and Translational Radiation Oncology|September 12, 2022
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general populationSophie D Fosså, Alv A Dahl, Tom Børge Johannesen, et al.Clinical Genitourinary Cancer|January 10, 2026
Postoperative Treatment and Survival in Locally Advanced Prostate Cancer: Real-World OutcomesAnne Holck Storås, Kaitlyn M Tsuruda, Tor Åge Myklebust, et al.Scandinavian Journal of Urology|April 7, 2016
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)Sophie D Fosså, Anne Holck Storås, Eivind A Steinsvik, et al.Asian Journal of Urology|April 8, 2020
A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomyAnne Holck Storås, Martin G Sanda, Olatz Garin, et al.Clinical Genitourinary Cancer|February 15, 2014
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatmentAnne Holck Storås, Martin G Sanda, Montse Ferrer, et al.Clinical Genitourinary Cancer|January 19, 2016
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish PatientsAnne Holck Storås, Martin G Sanda, Olatz Garin Boronat, et al.BJU International|March 12, 2024
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)Sven Löffeler, Helena Bertilsson, Christoph Müller, et al.Pageof 1